ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q2 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $224,000 | +58.9% | 20,266 | +20.6% | 0.01% | +50.0% |
| Q1 2017 | $141,000 | +67.9% | 16,800 | +1.4% | 0.00% | +100.0% |
| Q3 2016 | $84,000 | +61.5% | 16,562 | +44.1% | 0.00% | +100.0% |
| Q4 2015 | $52,000 | +73.3% | 11,492 | +14.8% | 0.00% | 0.0% |
| Q2 2015 | $30,000 | -74.4% | 10,013 | -74.7% | 0.00% | -50.0% |
| Q1 2015 | $117,000 | -81.3% | 39,519 | -66.8% | 0.00% | -80.0% |
| Q2 2014 | $625,000 | +1288.9% | 119,057 | +1008.3% | 0.01% | +900.0% |
| Q1 2014 | $45,000 | +66.7% | 10,742 | +0.3% | 0.00% | – |
| Q3 2013 | $27,000 | – | 10,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |